UTMD Q1 2024 Earnings Solid EPS Performance Amidst Cautious Market Reaction Perspective Therapeutics Inc CATX Q1 2026 Earnings EPS Beat by 17 as PreRevenue Biotech Advances Radiopharmaceutical Pipeline MSCI Q1 2026 Earnings Slight EPS Beat Supports Positive Market Response CHMI Q1 2026 Earnings EPS Surpasses Estimates Stock Advances Nexa Resources Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher Rapport Therapeutics Inc RAPP Q1 2026 Earnings NarrowerThanExpected Loss Drives Stock Gain